BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 12036915)

  • 21. Efficacy of SSG and SSG/IFNalpha2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor action.
    Li J; Lindner DJ; Farver C; Borden EC; Yi T
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):341-9. PubMed ID: 17103170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels.
    Verschoyle RD; Greaves P; Patel K; Marsden DA; Brown K; Steward WP; Gescher AJ
    Eur J Cancer; 2008 Apr; 44(6):898-906. PubMed ID: 18343654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein-3.
    Singh RP; Tyagi AK; Dhanalakshmi S; Agarwal R; Agarwal C
    Int J Cancer; 2004 Feb; 108(5):733-40. PubMed ID: 14696100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy of insulin-like growth factor binding protein-3 and retinoid X receptor ligands synergize on prostate cancer cell apoptosis in vitro and in vivo.
    Liu B; Lee KW; Li H; Ma L; Lin GL; Chandraratna RA; Cohen P
    Clin Cancer Res; 2005 Jul; 11(13):4851-6. PubMed ID: 16000583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
    London CA; Sekhon HS; Arora V; Stein DA; Iversen PL; Devi GR
    Cancer Gene Ther; 2003 Nov; 10(11):823-32. PubMed ID: 14605668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice.
    Yazici S; Kim SJ; Busby JE; He J; Thaker P; Yokoi K; Fan D; Fidler IJ
    Prostate; 2005 Nov; 65(3):203-15. PubMed ID: 15948138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
    Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
    Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.
    Flaig TW; Glodé M; Gustafson D; van Bokhoven A; Tao Y; Wilson S; Su LJ; Li Y; Harrison G; Agarwal R; Crawford ED; Lucia MS; Pollak M
    Prostate; 2010 Jun; 70(8):848-55. PubMed ID: 20127732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of mammary carcinogenesis in two rodent models by silymarin dietary supplements.
    Malewicz B; Wang Z; Jiang C; Guo J; Cleary MP; Grande JP; Lü J
    Carcinogenesis; 2006 Sep; 27(9):1739-47. PubMed ID: 16597642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.
    Wang X; Yuan S; Wang J; Lin P; Liu G; Lu Y; Zhang J; Wang W; Wei Y
    Toxicol Appl Pharmacol; 2006 Sep; 215(2):168-78. PubMed ID: 16563451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer.
    Bandyopadhyay A; Wang L; López-Casillas F; Mendoza V; Yeh IT; Sun L
    Prostate; 2005 Apr; 63(1):81-90. PubMed ID: 15468171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
    Tyagi A; Agarwal C; Harrison G; Glode LM; Agarwal R
    Carcinogenesis; 2004 Sep; 25(9):1711-20. PubMed ID: 15117815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis.
    Dhanalakshmi S; Mallikarjuna GU; Singh RP; Agarwal R
    Carcinogenesis; 2004 Aug; 25(8):1459-65. PubMed ID: 15033902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proliferation of DU145 prostate cancer cells is inhibited by suppressing insulin-like growth factor binding protein-2.
    Chatterjee S; Park ES; Soloff MS
    Int J Urol; 2004 Oct; 11(10):876-84. PubMed ID: 15479293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer.
    Hogan FS; Krishnegowda NK; Mikhailova M; Kahlenberg MS
    J Surg Res; 2007 Nov; 143(1):58-65. PubMed ID: 17950073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts.
    Venkateswaran V; Haddad AQ; Fleshner NE; Fan R; Sugar LM; Nam R; Klotz LH; Pollak M
    J Natl Cancer Inst; 2007 Dec; 99(23):1793-800. PubMed ID: 18042933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling.
    Mallikarjuna G; Dhanalakshmi S; Singh RP; Agarwal C; Agarwal R
    Cancer Res; 2004 Sep; 64(17):6349-56. PubMed ID: 15342425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells.
    Sharma G; Singh RP; Chan DC; Agarwal R
    Anticancer Res; 2003; 23(3B):2649-55. PubMed ID: 12894553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.